Dudediligence.

Q/C Technologies, Inc

QCLSNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$1.9MSep ’24−$2.1MDec ’24−$1.1MMar ’25−$1.8MJun ’25−$2.8MSep ’25−$5.9MDec ’25−$1.2MMar ’26−$6.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$28.8M−$15.3M−$17.1M−$10.2M−$9.8M
Net income−$29.9M−$15.2M−$4.0M−$23.4M−$11.6M
Operating cash flow−$19.5M−$12.3M−$13.0M−$9.0M−$9.1M
Free cash flownone on filenone on filenone on filenone on file−$10.8M
Cash$555,967$749,090$2.7M$173,154$986,996
Shares outstanding37.7M1.3M2.0M33.6K7.7M